Beaufort
UEI: SHVQS7WN26N4
• CAGE: 7UWY5
Overview
Awardee Type
Parent
Federal Capability Statement
Beaufort CRO specializes in supporting the development and regulatory approval of in vitro diagnostics (IVD) and medical devices. With expertise in clinical trial management, data management, biostatistics, regulatory affairs, and quality assurance, Beaufort provides strategic insights and operational excellence to help clients navigate complex regulatory pathways and achieve market authorization. The company focuses on mitigating risk and accelerating product timelines, particularly for diagnostics and medical technologies, ensuring the highest standards of quality and compliance across global markets.
Keywords
Clinical Research Organization, CRO, Clinical Trial Management, Clinical Monitoring Oversight, Invitro Diagnostics, FDA Regulatory Support
Quality Assurance Certifications
ISO-9000 Series
Website
Headquarters
Virginia Beach, VA
United States
United States
Federal recipient
BEAUFORT LLC
(UEI SHVQS7WN26N4, CAGE 7UWY5)
is headquartered in Virginia Beach VA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The partnership
was founded in January 2004 and
federally registered in
February 2017.
Federal Registration and Certifications
Legal Name
BEAUFORT LLC
UEI
SHVQS7WN26N4
CAGE Code
7UWY5
SBA Certifications
None
Self Certifications
None
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 15, 2004
Initial Registration
Feb. 16, 2017
Last Registration
Oct. 4, 2024
Registration Activation
Oct. 4, 2024
Registration Expiration
Oct. 2, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
VA
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No